Underweight: 10-15% Trim with $131 Stop and Put Spread Overlay
The Underweight with 10-15% trim honors three binding lessons: (1) structural floor ($664B RPO, IG rating, $37B cash buffer) rules out full Sell; (2) hostile but not broken technicals (below all MAs, MACD negative) rules out fresh Buy; (3) history shows trim magnitudes >20% systematically leak alpha in this ticker. The 12.94x forward P/E has absorbed most of the bear case (30% growth, 41% ROE, PEG 0.81). The $131 hard stop at 2.2 ATR provides calibrated noise tolerance beyond the Conservative Analyst's $137.25 stop.
| Position | Action |
|---|---|
| Default | Trim existing ORCL exposure by 10-15% at ~$143 |
Oracle is a world-class franchise with elite-tier profitability (41% ROE, 35.6% operating margin, 30% revenue growth) trading at a significant discount (13x forward P/E, PEG of 0.81) due to a 55% drawdown, creating an asymmetric opportunity as the company's $48.5 billion OCI infrastructure buildout converts to revenue over the next 10-15 years.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | 145.11 | bearish |
| close_200_sma | 161.65 | bearish |
| close_10_ema | 142.05 | neutral |
| macd | -1.51 | neutral |
| macds | -1.68 | neutral |
| macdh | +0.17 | bullish |
| rsi | 49.67 | neutral |
| boll_mid | 143.38 | neutral |
| boll_ub | 154.17 | bearish |
| boll_lb | 132.59 | bullish |
| atr | 6.31 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Technical setup shows exhaustion reversal signals, not continuation breakdown
↩ rebuts: “The Chart is Broken”
EV: +53% to $220+ (full re-rating to 18x forward) · concedes: The long-term trend is broken (stock below 200 SMA at $161.65); TTM Free Cash Flow is -$45.9 billion with $28.5B quarterly capex creating cash furnace appearance; Hawkish Fed backdrop is real (10Y at 2002 highs, Polymarket pricing 96% probability of zero rate cuts in 2026); The macro environment is challenging for speculative growth stocks; Forward P/E of 13x implies 72% EPS expansion if multiples don't change
The market is correctly pricing in structural risks—$89B net debt, -$45.85B TTM FCF, customer concentration in OpenAI, and unproven AI capex unit economics—that make 13x forward P/E a rational valuation, not a mispricing opportunity; the path to re-rating requires multiple low-probability events while further downside requires only one to fail.
EV: -12% to -25% · concedes: Oracle is a high-quality business; 13x forward earnings is mathematically below the software peer average; The AI capex story has real long-term potential; $48.5B in CIP, 41% ROE, 30% growth are accurate trailing and current metrics; There is a price at which ORCL is a buy—meaningfully below $143
→ vs conservative: Holding through a 55% drawdown hoping for a bounce is anchoring bias, not patience; what matters is the forward setup, not backward-looking price
→ vs neutral: MACD histogram green flip and RSI normalization are not confirmation; 50 SMA at $145.11 is resistance not support, and the MACD line remains below zero
→ vs neutral: Quality fundamentals (30% growth, >40% ROE) are already priced into 72% EPS expansion assumption requiring flawless execution on capex with rates elevated
→ vs neutral: AI infrastructure narrative supports Nvidia/AMD but Oracle is a leveraged buyer of AI capex, not a beneficiary; if market questions AI capex ROI, Oracle is first to get hit
→ vs conservative: Net debt $89B and negative $45.9B TTM FCF with $19.9B equity issuance and $26.7B debt issuance shows company cannot self-fund growth story
→ vs conservative: Zero retail sentiment across all platforms for $435B name indicates apathy, not strength; silence in a market making daily AI news means narrative has stalled
→ vs conservative: Sitting through drawdown hoping fundamentals save you is highest-risk position; 'patience' is paying premium to wait in a structurally broken setup
| vwma | ~141.52 | bullish |
Support: 141.3 · 132.59 · 127 · 125 | Resistance: 145.11 · 154.17 · 161.65 · 162.52
ORCL exhibits a mixed technical picture: long-term bearish trend confirmed by price 11.2% below the 200 SMA ($161.65), but short-term momentum is improving with MACD histogram expanding positively (+0.17) and RSI recovering to midline (49.67). The 50 SMA ($145.11) serves as the critical near-term pivot; a sustained close above $145.50 would flip medium-term bias from repair to reversal candidate. ATR of $6.31 (4.4% of price) signals elevated volatility requiring wider stops and reduced position sizing. VWMA at $141.52 confirms buyers absorbing supply for the first time since August. Recommendation: HOLD at the inflection point.
Market Cap
$435.2B
P/E (TTM)
22.50x
Forward P/E
13.05x
PEG Ratio
0.81
P/B Ratio
7.02x
EPS (TTM)
$6.38
Forward EPS
$10.997
Dividend Yield
1.38%
Beta
1.77
52-Week High
$322.54
52-Week Low
$114.50
50-Day MA
$144.64
200-Day MA
$162.49
Book Value/Share
$20.44
Revenue (TTM)
$71.78B
Gross Profit (TTM)
$45.91B
EBITDA (TTM)
$34.43B
Net Income (TTM)
$18.74B
Operating Margin
35.6%
Net Profit Margin
26.4%
Return on Equity (ROE)
41.2%
Return on Assets (ROA)
6.4%
Total Assets
$303.3B
Net PPE
$161.8B
Construction in Progress
$48.5B
Cash & Short-Term Investments
$37.1B
Total Debt
$155.9B
Capital Lease Obligations
$30.6B
Net Debt
$89.0B
Total Equity
$66.8B
Current Ratio
1.17x
Debt/Equity
251.7%
OCF (Q1 FY27)
$23.1B
CapEx (Q1 FY27)
-$28.50B
FCF (Q1 FY27)
-$5.40B
FCF (TTM)
-$45.85B
Stock Issued (Q1 FY27)
$19.91B
Dividends Paid (Q1 FY27)
-$1.57B
Q1 FY27 Revenue
$19,345M
Q1 FY27 Operating Income
$6,822M
Q1 FY27 EBITDA
$10,393M
Strengths
Concerns
Oracle is a mega-cap enterprise software and cloud infrastructure provider currently executing one of the largest physical infrastructure buildouts in corporate history to expand OCI capacity for AI workloads. The company delivered Q1 FY27 revenue of $19.3B (up 30% YoY) with elite profitability metrics including 41.2% ROE and 26.4% net margin, yet the stock trades near 52-week lows as investors grapple with deeply negative free cash flow (-$45.85B TTM), elevated leverage (D/E 251.7%), and ongoing equity dilution ($19.9B raised in Q1 FY27). The disconnect between accelerating fundamentals and depressed stock price creates a compelling risk/reward opportunity for patient long-term investors, though short-term traders should await price reclamation above key moving averages.
Macro: Hawkish rate regime confirmed: 10Y Treasury at highest since 2002 with biggest monthly move since 2022; Fed officials unified in warning inflation still too high; Polymarket pricing implies 96% probability of zero rate cuts in 2026; September jobs miss provided brief relief but did not alter structural picture; geopolitical inflation risk (Iran) adding upward pressure; Moody's Zandi and Goldman Sachs warning higher rates + ballooning US debt are damaging to macro outlook. AI mega-cap tech (Nvidia, AMD) bucking broader weakness, with Nasdaq at all-time highs.